Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Karamjeet S. Sandhu, Alan Macias, Marissa Del Real, Asuscena L. Beltran, Young Sun Kim, Jianying Zhang, Joycelynne Palmer, Marjorie Robbins, Reyna Loomis, Mojtaba Akhtari, Ahmed Aribi, Shukaib Arslan, Amandeep Salhotra, Matthew Mei, Hoda Pourhassan, Paul B. Koller, Idoroenyi Amanam, Vaibhav Agrawal, Peter T. Curtin, Ricardo Spielberger, Vinod A. Pullarkat, Ibrahim Aldoss, F. Mark Stewart, Eileen P. Smith, Stephen J Forman, Anthony S. Stein, Guido Marcucci, L. Elizabeth Budde
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310127360